| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2405355 | Vaccine | 2009 | 8 Pages |
Abstract
AimsTo estimate the cost-effectiveness of three behavioral interventions provided to enhance hepatitis A virus (HAV) and hepatitis B virus (HBV) joint vaccination (HAV/HBV) compliance among homeless persons living in Los Angeles County.ScopeA cost-effectiveness analysis (CEA) based on data from a randomized trial where the costs and compliance data from the trial are incorporated into two Markov models, simulating the natural history of acute and chronic hepatitis infection, following HAV/HBV vaccination.ConclusionsReductions in HBV-related disease is cost-effective to society and is associated with substantial improvements in quality of life.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Barbara Greengold, Adeline Nyamathi, Gerald Kominski, Dorothy Wiley, Mary Ann Lewis, Felicia Hodge, Mendel Singer, Brennan Spiegel,